---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-056363"
form_type: "8-K"
ticker: "DNLI"
cik: "0001714899"
company_name: "Denali Therapeutics Inc."
filed_at: "2025-12-10T23:59:59+00:00"
generated_at: "2026-05-16T13:39:10.146376+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Denali prices $200M public offering of common stock and pre-funded warrants

## Summary
- Prices 9.14M shares at $17.50 and 2.29M pre-funded warrants at $17.49, raising ~$200M gross proceeds.
- Underwriters granted 30-day option for additional 1.71M shares, potential total $230M gross proceeds.
- Offering expected to close Dec 11, 2025; Goldman Sachs, J.P. Morgan, Morgan Stanley, Jefferies as joint book-runners.
- Pre-funded warrants have $0.01 exercise price, immediately exercisable, with 4.99% beneficial ownership limitation.

## SEC filing metadata
- accession: 0001628280-25-056363
- form_type: 8-K
- ticker: DNLI
- cik: 0001714899
- company_name: Denali Therapeutics Inc.
- filed_at: 2025-12-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1714899/000162828025056363/0001628280-25-056363-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1714899/000162828025056363/dnli-20251209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-056363
- JSON: https://secwatch.observer/filing/0001628280-25-056363.json
- Plain text: https://secwatch.observer/filing/0001628280-25-056363.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.